Cell type-dependent and -independent control of HER-2/neu translation
Authors:
- 1 January 1999
- journal article
- research article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 31 (1) , 201-213
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cellsOncogene, 1997
- Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene.Molecular and Cellular Biology, 1990
- Induction of a variety of tumors by c‐erbB2 and clonal nature of lymphomas even with the mutated gene (Val659‐‐‐‐Glu659).The EMBO Journal, 1990
- Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.Proceedings of the National Academy of Sciences, 1987
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987
- Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptorNature, 1986
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenNature, 1984